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Steps Physiotherapy, 32 Southbourne Rd, Shefﬁeld S10 2QN, UKDespite an enormous body of evidence supporting the
positive effects of exercise, physical activity levels are
lower in patients with peripheral arterial disease (PAD)
than in age-matched controls.1 It has been shown that
walking speed is a good indicator for increased risk of
cardiovascular death. In a study with over 4000 partici-
pants aged 65e85, it was found that those in the lowest
third of walking speed had a 44% increased risk of death
compared with those in the upper thirds.2 Walking advice
alone is ineffective, as patients are usually non-compliant
because of lack of support and motivation.3 With this
sort of convincing data available, it is possible to see that
increasing the activity of these patients is of paramount
importance.
Wearable activity monitors are increasingly being used to
objectively monitor physical activity in research studies
within the ﬁeld of exercise science. Calibration and valida-
tion of these devices are vital to obtaining accurate data.
Bassett and Rowlands (2012)4 compared six different ac-
tivity monitors in a study where each patient wore six
different monitors at a time (one of these was the Dynaport
min mov), and performed an hour’s worth of activities
which were then compared for accuracy. Three were found
to be more accurate (the Dynaport was found to be
particularly accurate at walking speeds). Tri-axial activity
monitors are getting more and more sophisticated. They can
track how many steps taken, stairs climbed, distance trav-
elled, calories burned, and even quality of sleep. Some
measure heart rate, and have altimeters for greater accu-
racy. Most sync with mobile phones or computers, and have
websites to enable performance to be studied. Some have
red lights that turn green when patients have reached a
daily target of activity, and an algorithm that increases the
amount of work they have to do to obtain a green light.
The author attempts to validate the Dynaport move
monitor.5 Patients were ﬁlmed during a routine hospital
visit (wearing a Dynoport move monitor). Seven activities
were identiﬁed and data collected. Analysis showed that
the move monitor correlated best for walking activities,
both real life walking and treadmill walking, and worst for
‘shufﬂing’ or changing position activities (low sensitivity
46.2%). The main drawback of the Dynaport move monitor
is its cost. At 690 Euros it is one of the most expensive onDOI of original article: http://dx.doi.org/10.1016/j.ejvs.2014.04.003
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tween lying and sitting, sitting and standing, and shufﬂing
activity. Most of the other monitors available vary from 75
to 200 Euros, a much more affordable amount for use with
patients.
Walking on a treadmill (to record claudication distance
maximum walking distance) is an internationally respected
gold standard exercise test for these patients, but bears
little similarity to the exercise that patients experience in
their daily lives. The author suggests that activity monitoring
may be a more effective way of assessing the exercise ca-
pacity of these patients.
There is a need for more research in this area, and this
paper highlights the problems of validating these new
monitoring ‘tools’. Research comparing patient compli-
ance, looking at the use of activity monitors instead of
pedometers (which have already been shown to increase
patient compliance with exercise programmes6) is the
next logical step. Activity monitors can give positive
feedback to the patient immediately (by way of rewards
using an app on mobile phones, or lights that change
colour when targets are reached, and analysis of perfor-
mance), and may therefore be useful as a way of moti-
vating patients with peripheral arterial disease to take
more exercise.REFERENCES
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